87.8
Jasper Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
41.7
FY23:
88.9
FY24:
75.8
FY25:
34.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.82
FY22:
6.63
FY23:
5.95
FY24:
4.09
FY25:
1.13
Total assets
Change from FY21 to FY25
millions USD
FY21:
93.7
FY22:
48.4
FY23:
94.9
FY24:
79.9
FY25:
35.8
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.02
FY22:
7.07
FY23:
12.4
FY24:
15.2
FY25:
13.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.1
FY22:
5.31
FY23:
4.08
FY24:
2.99
FY25:
18.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
69.5
FY22:
36.0
FY23:
78.4
FY24:
61.7
FY25:
4.15
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
93.7
FY22:
48.4
FY23:
94.9
FY24:
79.9
FY25:
35.8
All amounts in millions USD